In the heart, variations in certain renin-angiotensin system (RAS) components are frequently observed in the conditions leading to HF progression, such as ACE and angiotensin II type 1 receptor (AT1) [200–202]. This evidence concerns the gene AGTR1 and hydrops fetalis.